Visual hallucination in craniometaphyseal dysplasia successfully treated with olanzapine

Journal of Pharmacy Technology

Volumn 16, Issue 6, 2000, Pages 241-243

  Alao, A O ^a   Armenta, W A ^a   Yolles, J C ^a   Naprawa, S A ^a  

^a University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADOLESCENT; ARTICLE; BLINDNESS; BONE TISSUE; CASE REPORT; CRANIOTOMY; DOSE RESPONSE; DYSPLASIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; TREATMENT OUTCOME; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 0033653108     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250001600604     Document Type: Article

References (15)

1. Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and management
2. Charles Bonnet syndrome: Early marker for dementia?
3. Therapeutic options in Charles Bonnet syndrome
4. Visual hallucinations as release phenomena
5. Visual hallucinations after acute visual loss in a young child
6. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways
7. Visual hallucinations and sensory delusions in the elderly
8. Complex visual hallucinations in the hemianopic field
9. Visual hallucinations in blindness: The Charles Bonnet syndrome
10. The Charles Bonnet syndrome: A review
11. Charles Bonnet syndrome
12. Charles Bonnet syndrome
13. Cisapride in the treatment of visual hallucinations caused by vision loss: The Charles Bonnet syndrome
14. High-dose olanzapine therapy in schizophrenia
15. Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: A cautionary note